RDY
Dr. Reddy’s Laboratories Ltd
12.60$
-1.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.6% | 41.5% | 41.4% | 39.6% | 40.4% | 41.3% | 44.4% | 43.1% | 45.3% | 46.4% | 55.2% | 53.5% | 49.8% | |
| 56.4% | 58.5% | 58.6% | 60.4% | 59.6% | 58.7% | 55.6% | 56.9% | 54.7% | 53.6% | 44.8% | 46.5% | 50.2% | |
| 7.9% | 7.7% | 9.7% | 8.1% | 9.1% | 8.0% | 8.5% | 7.3% | 7.0% | 7.0% | 7.3% | 7.1% | 7.1% | |
| 3,467.7% | 28.0% | 28.9% | 29.6% | 28.7% | 28.9% | 28.3% | 27.1% | 30.0% | 18.2% | 19.0% | 32.1% | 24.9% | |
| 35.2% | 35.1% | 37.4% | 37.0% | 37.7% | 36.3% | 34.8% | 36.5% | 34.8% | 37.3% | 44.2% | 42.9% | 39.6% | |
| 21.1% | 23.9% | 21.1% | 23.4% | 21.9% | 22.4% | 20.7% | 20.5% | 19.9% | 16.3% | 0.6% | 3.7% | 10.6% | |
| 42.4% | 0.5% | 0.8% | 0.8% | 0.9% | 1.0% | 0.8% | 1.0% | 1.0% | 1.1% | 1.4% | 1.6% | 1.3% | |
| 27.8% | 25.3% | 22.6% | 24.5% | 23.9% | 22.4% | 23.6% | 22.3% | 20.8% | 17.7% | 2.6% | 6.8% | 12.4% | |
| 6.3% | 6.2% | 4.2% | 6.4% | 7.2% | 5.6% | 4.9% | 5.8% | 4.6% | 4.0% | -0.3% | 1.5% | 2.6% | |
| 21.5% | 19.1% | 18.5% | 18.1% | 15.7% | 16.9% | 18.7% | 16.6% | 16.3% | 13.9% | 2.9% | 5.5% | 10.0% | |
| 33.8% | 29.5% | 28.7% | 28.4% | 29.8% | 29.0% | 29.7% | 28.8% | 27.6% | 22.4% | 11.5% | 3.7% | 16.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.